| Patent | Date |
|---|
Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
Grant 7,601,739 - Danso-Danquah , et al. October 13, 2 | 2009-10-13 |
Anti-sickling agents
Grant 7,160,910 - Safo , et al. January 9, 2 | 2007-01-09 |
Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
App 20060287359 - Danso-Danquah; Richmond ; et al. | 2006-12-21 |
Anti-sickling agents
Grant 7,119,208 - Safo , et al. October 10, 2 | 2006-10-10 |
Anti-sickling agents
App 20050209199 - Safo, Martin K. ; et al. | 2005-09-22 |
Substituted chiral allosteric hemoglobin modifiers
App 20050154062 - Abraham, Donald J. ; et al. | 2005-07-14 |
Substituted chiral allosteric hemoglobin modifiers
Grant 6,894,185 - Abraham , et al. May 17, 2 | 2005-05-17 |
Anti-sickling agents
App 20040157801 - Safo, Martin K. ; et al. | 2004-08-12 |
Board game for teaching DNA concepts
App 20040113362 - Hardwicke, Susan B. ; et al. | 2004-06-17 |
Substituted chiral allosteric hemoglobin modifiers
App 20030130523 - Abraham, Donald J. ; et al. | 2003-07-10 |
Allosteric inhibitors of pyruvate kinase
Grant 6,534,501 - Abraham , et al. March 18, 2 | 2003-03-18 |
Substituted chiral allosteric hemoglobin modifiers
Grant 6,486,342 - Abraham , et al. November 26, 2 | 2002-11-26 |
Allosteric inhibitors of pyruvate kinase
App 20010046997 - Abraham, Donald J. ; et al. | 2001-11-29 |
Allosteric inhibitors of pyruvate kinase
Grant 6,214,879 - Abraham , et al. April 10, 2 | 2001-04-10 |
Allosteric modifiers of hemoglobin
Grant 5,927,283 - Abraham , et al. July 27, 1 | 1999-07-27 |
Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors
Grant 5,705,521 - Abraham January 6, 1 | 1998-01-06 |
Medical uses of allosteric hemoglobin modifier compounds in patient care
Grant 5,677,330 - Abraham , et al. October 14, 1 | 1997-10-14 |
Use of hydrophobic compounds and anesthetics in combination with allosteric hemoglobin modifiers
Grant 5,648,375 - Abraham July 15, 1 | 1997-07-15 |
Allosteric modifiers of hemoglobin
Grant 5,591,892 - Abraham , et al. January 7, 1 | 1997-01-07 |
Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
Grant 5,432,191 - Abraham , et al. * July 11, 1 | 1995-07-11 |
Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
Grant 5,290,803 - Abraham , et al. * March 1, 1 | 1994-03-01 |
Allosteric hemoglobin modifiers useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
Grant 5,122,539 - Abraham , et al. June 16, 1 | 1992-06-16 |
Allosteric hemoglobin modifiers
Grant 5,049,695 - Abraham , et al. September 17, 1 | 1991-09-17 |
Method of treating sickle cell anemia
Grant 4,887,995 - Abraham , et al. December 19, 1 | 1989-12-19 |
Tritium labelled N-mustard type compounds and a process for their production
Grant 4,795,627 - Fisher , et al. January 3, 1 | 1989-01-03 |
Compounds useful in treating sickle cell anemia
Grant 4,751,244 - Abraham , et al. June 14, 1 | 1988-06-14 |
Compounds useful in treating sickle cell anemia
Grant 4,731,473 - Abraham , et al. March 15, 1 | 1988-03-15 |
Method of treating a person for sickle cell anemia
Grant 4,731,381 - Abraham , et al. March 15, 1 | 1988-03-15 |
Method of treating sickle cell anemia
Grant 4,704,402 - Abraham , et al. November 3, 1 | 1987-11-03 |
Sickle cell anemia treatment and compound
Grant 4,482,571 - Abraham November 13, 1 | 1984-11-13 |
| 